Pathstone Family Office’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$13.8K Buy
+421
New +$13.8K ﹤0.01% 1649